PMID: 17972821Mar 1, 1994

Blockade of 5-HT2 receptors as a mechanism of antihypertensive action of ketanserin

Srpski arhiv za celokupno lekarstvo
M Prostran

Abstract

Ketanserin is a selective 5-HT2-receptor antagonist. The drug blocks 5-HT2-mediated effects of serotonin on blood vessels and platelets, both in experimental animals as well as in humans. Ketanserin is a useful antihypertensive drug especially in elderly patients. Its precise mechanism of antihypertensive action in humans is unknown. This effect cannot be only explained by 5-HT2- or alpha1-receptor antagonistic properties (higher doses) of the drug. Ketanserin may also be used in the treatment of some peripheral vascular diseases (e.g. Raynaud's phenomenon) as well as of carcinoid syndrome. The drug has a few, usually mild side effects. The usual dosage of ketanserin in the treatment of hypertension or vasospastic diseases is 40 to 80 mg per day, in two divided doses. Doses higher than 80 mg per day should be avoided, because of the side effects, therapeutic efficacy remaining unchanged.

Related Concepts

Antihypertensive Agents
Hypertensive Disease
R-41,468
Serotonin Antagonists
Vascular Diseases

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.